Crebanine is an
alkaloid known to exhibit anticancer, but its mechanism is not well understood. Besides, the
nuclear factor-kappa B (NF-κB)
transcription factor has been correlated with
inflammation,
carcinogenesis,
tumor cell survival, invasion, and angiogenesis. In this study, we investigated the effects of
crebanine on
tumor necrosis factor alpha (TNF-α)-induced NF-κB activation and the expression of NF-κB-regulated gene products. We found that
crebanine reduced the cell proliferation of lung, ovarian, and
breast cancer cells.
Crebanine also potentiated TNF-α-induced apoptosis which correlated with the suppression of the gene products linked to cell survival,
B cell lymphoma-extra large, and proliferation,
cyclin D1. In addition,
crebanine affected TNF-α-induced activation of
caspase-8,
caspase-3, and
poly(ADP-ribose) polymerase cleavage, indicating that the apoptotic effects of TNF-α were enhanced by
crebanine. Moreover,
crebanine reduced TNF-α-induced A549 cell invasion and migration. Furthermore,
crebanine suppressed the TNF-α-mediated expression of
proteins that involved
cancer cell invasion (
matrix metalloproteinase 9 urokinase-type plasminogen activator,
urokinase-type plasminogen activator receptor and
intercellular adhesion molecule 1) and angiogenesis (COX-2 and
VEGF), all of which are known to be regulated by NF-κB. We also demonstrated that TNF-α induced NF-κB
DNA-binding activity, which was inhibited by
crebanine. Moreover,
crebanine suppressed the TNF-α-induced degradation of inhibitor of NF-κB alpha (IκBa), which led to reduced NF-κB translocation to the nucleus. Taken together, our results demonstrated that
crebanine reduced TNF-α-induced
cancer cell proliferation, invasion, and survival by suppressing NF-κB activity and expression profile of its downstream genes.